Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/2010
10/28/2010WO2010123008A1 Method for evaluating skin barrier function recovery-accelerator using work function as indication
10/28/2010WO2010122980A1 Novel thyroid hormone β receptor agonist
10/28/2010WO2010122979A1 Thiazolidinone derivative
10/28/2010WO2010122968A1 Diacylethylenediamine compound
10/28/2010WO2010122927A1 Pharmaceutical agent for prevention or treatment of retarded nerve regeneration induced by diabetes
10/28/2010WO2007028030A3 Oncogenic regulatory rnas for diagnostics and therapeutics
10/28/2010US20100275329 Production of provitamin a carotenoids in mushrooms and uses thereof
10/28/2010US20100273849 Metalloproteinase Inhibitors
10/28/2010US20100273776 Inhibition of alpha-synuclein toxicity
10/28/2010US20100273757 Pyrazine derivatives useful as adenosine receptor antagonists
10/28/2010US20100273737 Supplementary food composition for reducing body odor
10/28/2010US20100273705 Method for inhibiting "Melanoma Inhibitory Activity" MIA
10/28/2010US20100273265 for inducing differentiation into retinal photoreceptor cells; for preventing/treating/suppressing progression of retinal diseases; retinitis pigmentosa, senile macular degeneration, diabetic retinopathy, retinal detachment, glaucoma and retinal vessel occlusion
10/28/2010US20100272826 Nano/macroporous bone tissue scaffolds for regenerative medicine
10/28/2010US20100272802 Compositions comprising strontium and uses thereof in the treatment or prevention of gingivitis, periodontitis, periodontitis as a manifestation of systemic diseases, and necrotizing periodontal diseases
10/28/2010US20100272783 Methods of Treating Infections of the Nail
10/28/2010US20100272782 Acellular tissue matrix compositions for tissue repair
10/28/2010US20100272705 Decontaminant edible product, methods of production and uses thereof
10/28/2010US20100272672 Crosslinked hydrogels
10/28/2010US20100272660 Cosmetic or pharmaceutical composition comprising a polycondensate, the said polycondensate and method of cosmetic treatment
10/28/2010US20100272655 Menthylcarboxamides and Their Use as Cooling Agents
10/28/2010US20100272653 Contrast Medium for Use in Imaging Methods
10/28/2010US20100272652 Determination of tracers within subjects
10/28/2010US20100272645 Myocardial perfusion imaging method
10/28/2010US20100272644 Complexation of fatty acid-conjugated molecules with albumin
10/28/2010DE202009012983U1 Neue therapeutische Konzepte für die Behandlung von Fibromyalgien New therapeutic approaches for the treatment of fibromyalgia
10/28/2010CA2759457A1 Association of htra1 mutations and familial ischemic cerebral small-vessel disease
10/28/2010CA2759264A1 Diacylethylenediamine compound
10/28/2010CA2758894A1 Novel thyroid hormone .beta. receptor agonist
10/27/2010EP2243779A1 Bicyclic heterocyclic derivative
10/27/2010EP2243778A1 Piperidine derivative
10/27/2010EP2243776A1 Substituted piperidines and their use for the treatment of diseases related to the histamine H3 receptor
10/27/2010EP2242496A1 Methods for in vitro maturation of ovarian follicles
10/27/2010EP1487877B1 Compositions and methods for the diagnosis of tumors
10/27/2010EP1330293B2 Controlled release composition comprising lactic acid polymer, and method of producing the same
10/27/2010EP1305036B1 Nutritional composition
10/27/2010EP1218509B9 Fibroblast growth factor-like polypeptides
10/27/2010EP0975609B1 Process for the crystallization of a reverse transcriptase inhibitor using an anti-solvent
10/27/2010CN1671381B Pramipexole once-daily dosage form
10/27/2010CN1585640B N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation
10/27/2010CN1585633B Phenethanolamine derivatives for treatment of respiratory diseases
10/27/2010CN101874042A Method of modifying isoelectric point of antibody via amino acid substitution in cdr
10/27/2010CN101873854A Laminins, derivatives, and compositions including same and method for their therapeutic use
10/27/2010CN101873853A Compound and use thereof in the treatment of amyloidosis
10/27/2010CN101869716A System for monitoring bacterial tumor treatment
10/27/2010CN101869661A Chinese medicinal oral liquid for treating vocal nodule
10/27/2010CN101869649A Traditional Chinese medicine for treating hernia
10/27/2010CN101102773B Aminopyrazine analogs for treating glaucoma and other RHO kinase-mediated diseases
10/26/2010USRE41895 Epothilone derivatives
10/26/2010USRE41893 Epothilone derivatives
10/26/2010US7820819 inhibitors of immunoglobulin E or G receptor signaling cascades; Syk kinase inhibitors; use as antiallergic, antiinflammatory agents
10/26/2010US7820814 Inhibitors of kinases
10/26/2010US7820792 isoform of the alpha 2 delta -4 subunit of a voltage gated calcium channel; useful to identify modulators of the channel subunit; for cancer and inflammation
10/26/2010US7820717 4-Chloro-2-phenylsulfanyl-phenyl)-4-isopropoxy-benzenesulfonamide; inflammatory bowl disease such as Crohn's disease or Colitis
10/26/2010US7820715 Chemical intermediates; neurodegenerative disorders
10/26/2010US7820714 Increased selectivity for sialic acid binding Ig-like lectins (Siglec); improving immune response dependent on B-cells
10/26/2010US7820697 1-Oxo-2-(2,6-dioxopiperidin-3-yl)-4-methylisoindoline; treatment of cancers, rheumatoid arthritis, inflammatory bowel disease, muscular dystrophy, Crohn's disease and viral disease
10/26/2010US7820694 Administering an aminoindanyl derivative and; a steroid, dopamine receptor agonist or an anticholinergic or antimuscarinic agent; respiratory system disorders, antiallergens, chronic obstructive pulmonary disease, adult respiratory distress syndrome, bronchitis
10/26/2010US7820679 N-(-3-methoxy-5-methylpyrazin-2-yl)-2-(4-′1,3,4-oxadiazol-2-yl-phenyl)pyridine-3 sulphonamide as an anticancer agent
10/26/2010US7820671 Peptidomimetic protease inhibitors
10/26/2010US7820660 N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
10/26/2010US7820645 Crystalline forms
10/26/2010US7820641 Bactericides; antitumor agents; moderators of gene expression; viricides; parasiticides; malaria therapy
10/26/2010US7820627 with core structure of pentaerythritol used as replacement for sugars; immunomodulators; immunogens within liposomes; tumor antigens; for use as haptens, inhibitors of bacterial-host cell adhesion; septic shock
10/26/2010US7820440 Using vector comprising early gene modifications as genetic transfer element in gene therapy; gnentic vaccines
10/26/2010US7820400 Tumor-associated marker
10/26/2010US7820395 diagnostic method and vaccine using a composition comprising truncated r47 protein and truncated r56 protein; reducing HIV viral loads
10/26/2010US7820197 Using bisphosphonic acid compound; mixture with solubilizer; permeability through skin
10/26/2010US7820178 VEGF isoforms and their use as anti-angiogenic, anti-vasodilatory, anti-permeability and anti-proliferative agents
10/26/2010US7820170 monoclonal antibody exhibit antagonist activity of the anti-CD40 antibody; antiproliferative agents; controlling cell differentiation; anticarcinogenic agents; Hodgkin's disease, leukemias
10/26/2010US7820169 inhibiting the activity of tumor necrosis factor TNF in a patient having rheumatoid arthritis or psoriatic arthritis, by administering a composition comprising an effective amount of human anti-TNF antibody comprising a heavy chain variable region comprising SEQ ID NO:7 and a light chain variable
10/26/2010CA2543650C A crystalline form of the salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide or the solvate of the salt and a process for preparing thesame
10/26/2010CA2449192C Novel nitriles useful as reversible inhibitors of cysteine proteases
10/26/2010CA2434608C Promoting cell regeneration and/or cell differentiation with non-metabolizable sugar and a polymeric absorbent
10/26/2010CA2422708C 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
10/26/2010CA2418921C Novel composition
10/26/2010CA2417190C New beta-amyloid inhibitors, processes for preparing them and their use as pharmaceutical compositions
10/26/2010CA2412164C Amidine derivatives as selective antagonists of nmda receptors
10/26/2010CA2410594C Heterocyclic aminoalkylpyridine derivatives as psychopharmaceuticals
10/26/2010CA2400700C Antiviral azaindole derivatives
10/26/2010CA2396956C Polypharmacophoric agents
10/26/2010CA2293436C Imidazolyl-cyclic acetals as tnf inhibitors
10/26/2010CA2284733C Motilin homologs
10/26/2010CA2192928C Benzoheterocyclic derivatives
10/26/2010CA2133323C Self-assembling polynucleotide delivery system
10/21/2010WO2010119990A1 Pharmaceutical compositions
10/21/2010WO2010119984A1 3-aryl or heteroaryl-substituted indole derivative
10/21/2010WO2010119955A1 Agent for preventing, inhibiting, or ameliorating skin aging due to buildup of advanced glycation end products
10/21/2010WO2010119875A1 Fused pyrrolopyridine derivative
10/21/2010WO2010119741A1 Preparation for external use
10/21/2010WO2010119700A1 Novel compound having 3-heteroarylpyrimidin-4-(3h)-one structure and pharmaceutical preparation containing same
10/21/2010WO2010089443A3 PHARMACEUTICAL COMPOSITIONS COMPRISING TGF- β1 INHIBITOR PEPTIDES
10/21/2010WO2010056985A3 Treatment of proteinopathies using a farnesyl transferase inhibitor
10/21/2010WO2009096245A9 Pharmaceutical composition and combined agent
10/21/2010US20100268329 Drug/Drug Delivery Systems For The Prevention And Treatment Of Vascular Disease
10/21/2010US20100267936 PROCESS FOR CORRECTION OF A DISULFIDE MISFOLD IN Fc MOLECULES
10/21/2010US20100267930 SLO2 and SLO4, Novel Potassium Channel Proteins from Human Brain
10/21/2010US20100267846 Molecular delivery vehicle
10/21/2010US20100267844 Alkylene oxide-capped secondary alcohol alkoxylates useful as surfactants
10/21/2010US20100267830 Methods and compositions for promoting the neurological development of an infant